CD20-Specific Chimeric Antigen Receptor-Expressing T Cells As Salvage Therapy in Rituximab-Refractory CD20(+) B-Cell Non-Hodgkin Lymphoma

Rituxan (rituximab) - Biogen, Zenyaku Kogyo, Roche

CD20 specific CAR T - Central South University, Shanghai Unicar

Xin Li1; Qian Cheng1; Rui Liu1; Liqing Kang2; Nan Xu2,3; Minghao Li2,3; Lei Yu2,3

Nov 5, 2021